Healthcare is one of the most active M&A sectors globally and a key sector for Translink. Investors maintain a particularly high level of interest in the pharmaceuticals, life sciences, and healthcare services sectors. These transactions are driven by different factors including market disruption and consolidation.

Our primary focus is pharmaceuticals, healthcare equipment and supplies, distribution (of equipment and supplies), biotechnology, healthcare facilities and healthcare services.

We recognise the importance of having a profound understanding of the sector in order to evaluate our clients’ business and be able to screen the market for relevant targets or buyers.